Methodical approaches of estimation of probiotics` quality and rational principles of their usage in clinical practice

Authors

  • Liudmyla Lazarenko D. K. Zabolotny Institute of Microbiology and Virology of National Academy of Sciences of Ukraine Akademika Zabolotnoho str., 154, Kyiv, Ukraine, 03143, Ukraine https://orcid.org/0000-0002-2341-5677
  • Rostyslav Bubnov D. K. Zabolotny Institute of Microbiology and Virology of National Academy of Sciences of Ukraine Akademika Zabolotnoho str., 154, Kyiv, Ukraine, 03143, Ukraine https://orcid.org/0000-0003-3148-9884
  • Lidiia Babenko PhD, Researcher Department of Interferon and Immunomodulators, Ukraine https://orcid.org/0000-0003-1608-3990
  • Oleksandra Melnykova Educational Scientific Center "Institute of Biology and Medicine" Taras Shevchenko National University of Kyiv Volodymyrska str., 64/13, Kyiv, Ukraine, 01601, Ukraine https://orcid.org/0000-0002-5605-0782
  • Mykola Spivak D. K. Zabolotny Institute of Microbiology and Virology of National Academy of Sciences of Ukraine Akademika Zabolotnoho str., 154, Kyiv, Ukraine, 03143, Ukraine https://orcid.org/0000-0002-4394-7275

DOI:

https://doi.org/10.15587/2519-8025.2020.202216

Keywords:

probiotics, disease, estimation, safety, clinical practice, therapy

Abstract

Recently probiotics have been started to be commonly used as a subsidiary therapy during many illnesses, such as intestinal and urogenital infections, diseases of the gastrointestinal and respiratory tract, also joints and connective tissue lesions, some cancers, allergies, dermatological and dental diseases. However, there are still no summary guidelines for selection and estimation of probiotic strains for different clinical cases. Thus, we have made a general conclusion of estimation of probiotics` quality and development of rational principles of probiotic therapy usage in clinical practice during the treatment of patients with the most common diseases and for their prevention. There are described key principles of implementation of step-by-step estimation of probiotic culture quality in foodstuff according to regulations of World Health Organization, European Union, Ukraine and other countries. The requirements are presented for the evaluation of safety of probiotic cultures, which include testing of their in vitro and in vivo activity in different experimental models, as well as a study of their therapeutic efficacy in clinical practice in the treatment of patients and in long periods after probiotic therapy. Also there are some evidences of possible side effects, risks or low efficiency that depends on individual characteristics of the gut microbiota quantitative and qualitative composition of each patient and stage, heaviness of clinical course of each specific disease. That`s why it is very important to take all circumstances of patients` status into account and collect all previous stored knowledge of probiotics` usage

Author Biographies

Liudmyla Lazarenko, D. K. Zabolotny Institute of Microbiology and Virology of National Academy of Sciences of Ukraine Akademika Zabolotnoho str., 154, Kyiv, Ukraine, 03143

Doctor of Biological Sciences, Senior Researcher, Leading Researcher

Department of Interferon and Immunomodulators

Rostyslav Bubnov, D. K. Zabolotny Institute of Microbiology and Virology of National Academy of Sciences of Ukraine Akademika Zabolotnoho str., 154, Kyiv, Ukraine, 03143

PhD, Senior Researcher

Department of Interferon and Immunomodulators

Lidiia Babenko, PhD, Researcher Department of Interferon and Immunomodulators

D. K. Zabolotny Institute of Microbiology and Virology of National Academy of Sciences of Ukraine

Akademika Zabolotnoho str., 154, Kyiv, Ukraine, 03143

Oleksandra Melnykova, Educational Scientific Center "Institute of Biology and Medicine" Taras Shevchenko National University of Kyiv Volodymyrska str., 64/13, Kyiv, Ukraine, 01601

Department of Microbiology and Immunology

Mykola Spivak, D. K. Zabolotny Institute of Microbiology and Virology of National Academy of Sciences of Ukraine Akademika Zabolotnoho str., 154, Kyiv, Ukraine, 03143

Doctor of Biological Sciences, Professor, Corresponding Member of National Academy of Sciences of Ukraine, Head of Department

Department of Interferon and Immunomodulators

References

  1. Shirobokov, V. P., Shirobokov, V. P., Iankovskii, D. S., Dyment, G. S. (2010). Mikrobnaia ekologiia cheloveka s tsvetnym atlasom. Kyiv: Chervona Ruta-Turs, 340.
  2. Williams, N. T. (2010). Probiotics. American Journal of Health-System Pharmacy, 67 (6), 449–458. doi: http://doi.org/10.2146/ajhp090168
  3. Halloran, K., Underwood, M. A. (2019). Probiotic mechanisms of action. Early Human Development, 135, 58–65. doi: http://doi.org/10.1016/j.earlhumdev.2019.05.010
  4. Nichols, R. G., Peters, J. M., Patterson, A. D. (2019). Interplay Between the Host, the Human Microbiome, and Drug Metabolism. Human Genomics, 13 (1). doi: http://doi.org/10.1186/s40246-019-0211-9
  5. Azad, M. A. K., Sarker, M., Wan, D. (2018). Immunomodulatory Effects of Probiotics on Cytokine Profiles. BioMed Research International, 2018, 1–10. doi: http://doi.org/10.1155/2018/8063647
  6. Falagas, M. E., Betsi, G. I., Tokas, T., Athanasiou, S. (2006). Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs, 66 (9), 1253–1261. doi: http://doi.org/10.2165/00003495-200666090-00007
  7. Di Cerbo, A., Palmieri, B., Aponte, M., Morales-Medina, J. C., Iannitti, T. (2015). Mechanisms and therapeutic effectiveness of lactobacilli. Journal of Clinical Pathology, 69 (3), 187–203. doi: http://doi.org/10.1136/jclinpath-2015-202976
  8. Kasińska, M. A., Drzewoski, J. (2015). Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Polish Archives of Internal Medicine, 125 (11), 803–813. doi: http://doi.org/10.20452/pamw.3156
  9. Hendijani, F., Akbari, V. (2018). Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: A systematic review and meta-analysis. Clinical Nutrition, 37 (2), 532–541. doi: http://doi.org/10.1016/j.clnu.2017.02.015
  10. Didari, T., Mozaffari, S., Nikfar, S., Abdollahi, M. (2015). Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology, 21 (10), 3072–3084. doi: http://doi.org/10.3748/wjg.v21.i10.3072
  11. Wang, F., Feng, J., Chen, P., Liu, X., Ma, M., Zhou, R. et. al. (2017). Probiotics in Helicobacter pylori eradication therapy: Systematic review and network meta-analysis. Clinics and Research in Hepatology and Gastroenterology, 41 (4), 466–475. doi: http://doi.org/10.1016/j.clinre.2017.04.004
  12. Huang, R., Wang, K., Hu, J. (2016). Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 8 (8), 483. doi: http://doi.org/10.3390/nu8080483
  13. Chang, Y.-S., Trivedi, M. K., Jha, A., Lin, Y.-F., Dimaano, L., García-Romero, M. T. (2016). Synbiotics for Prevention and Treatment of Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials. JAMA Pediatrics, 170 (3), 236–242. doi: http://doi.org/10.1001/jamapediatrics.2015.3943
  14. Miller, L. E., Lehtoranta, L., Lehtinen, M. J. (2019). Short-term probiotic supplementation enhances cellular immune function in healthy elderly: systematic review and meta-analysis of controlled studies. Nutrition Research, 64, 1–8. doi: http://doi.org/10.1016/j.nutres.2018.12.011
  15. Kasatpibal, N., Whitney, J. D., Saokaew, S., Kengkla, K., Heitkemper, M. M., Apisarnthanarak, A. (2017). Effectiveness of Probiotic, Prebiotic, and Synbiotic Therapies in Reducing Postoperative Complications: A Systematic Review and Network Meta-analysis. Clinical Infectious Diseases, 64 (suppl_2), S153–S160. doi: http://doi.org/10.1093/cid/cix114
  16. Singhi, S. C., Kumar, S. (2016). Probiotics in critically ill children. F1000Research, 5, 407. doi: http://doi.org/10.12688/f1000research.7630.1
  17. Mantegazza, C., Molinari, P., D’Auria, E., Sonnino, M., Morelli, L., Zuccotti, G. V. (2018). Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment. Pharmacological Research, 128, 63–72. doi: http://doi.org/10.1016/j.phrs.2017.08.001
  18. Hooijmans, C. R., de Vries, R. B. M., Rovers, M. M., Gooszen, H. G., Ritskes-Hoitinga, M. (2012). The Effects of Probiotic Supplementation on Experimental Acute Pancreatitis: A Systematic Review and Meta-Analysis. PLoS ONE, 7 (11), e48811. doi: http://doi.org/10.1371/journal.pone.0048811
  19. Athalye-Jape, G., Rao, S., Patole, S. (2017). Effects of probiotics on experimental necrotizing enterocolitis: a systematic review and meta-analysis. Pediatric Research, 83 (1), 16–22. doi: http://doi.org/10.1038/pr.2017.218
  20. Million, M., Angelakis, E., Paul, M., Armougom, F., Leibovici, L., Raoult, D. (2012). Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microbial Pathogenesis, 53 (2), 100–108. doi: http://doi.org/10.1016/j.micpath.2012.05.007
  21. Mokrozub, V. V., Lazarenko, L. M., Babenko, L. P. (2013). Antistaphylococcal action of lacto- and bifidobacteria and interleukine-2. Mikrobiological Journal, 75 (6), 17–21.
  22. Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S. et. al. (2018). Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell, 174 (6), 1406–1423. doi: http://doi.org/10.1016/j.cell.2018.08.047
  23. Zhong, C., Qu, C., Wang, B., Liang, S., Zeng, B. (2017). Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. Journal of Clinical Gastroenterology, 51 (4), 300–311. doi: http://doi.org/10.1097/mcg.0000000000000814
  24. Wojtyniak, K., Szajewska, H. (2017). Systematic review: probiotics for functional constipation in children. European Journal of Pediatrics, 176 (9), 1155–1162. doi: http://doi.org/10.1007/s00431-017-2972-2
  25. Ng, Q. X., Soh, A. Y. S., Venkatanarayanan, N., Ho, C. Y. X., Lim, D. Y., Yeo, W.-S. (2019). A Systematic Review of the Effect of Probiotic Supplementation on Schizophrenia Symptoms. Neuropsychobiology, 78 (1), 1–6. doi: http://doi.org/10.1159/000498862
  26. Bo, L., Li, J., Tao, T., Bai, Y., Ye, X., Hotchkiss, R. S. et. al. (2014). Probiotics for preventing ventilator-associated pneumonia. Cochrane database of systematic reviews, 10 (10), 1465–1858. doi: http://doi.org/10.1002/14651858.cd009066.pub2
  27. Oliveira, L. V. N. de, Bastos, R. W., Ribeiro, N. de Q., Costa, M. C., Acurcio, L. B., Rocha, K. M. et. al. (2017). In vivo probiotic and antimicrobial photodynamic therapy as alternative therapies against cryptococcosis are ineffective. Veterinary Microbiology, 211, 169–173. doi: http://doi.org/10.1016/j.vetmic.2017.08.015
  28. Shentsova, M. A., Surmasheva, O. V. (2014). Probiotic preparations, their quality and safety: current state (part II). Dovkillia i zdorovia, 1, 64–69.
  29. Timmerman, H. M., Niers, L. E. M., Ridwan, B. U., Koning, C. J. M., Mulder, L., Akkermans, L. M. A. et. al. (2007). Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clinical Nutrition, 26 (4), 450–459. doi: http://doi.org/10.1016/j.clnu.2007.04.008
  30. Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S. et. al. (2018). Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell, 174 (6), 1388–1405. doi: http://doi.org/10.1016/j.cell.2018.08.041
  31. Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W. M. (1998). Demonstration of safety of probiotics – a review. International Journal of Food Microbiology, 44 (1-2), 93–106. doi: http://doi.org/10.1016/s0168-1605(98)00128-7
  32. Marteau, P., Seksik, P., Jian, R. (2002). Probiotics and health: new facts and ideas. Current Opinion in Biotechnology, 13 (5), 486–489. doi: http://doi.org/10.1016/s0958-1669(02)00368-3
  33. Snydman, D. R. (2008). The Safety of Probiotics. Clinical Infectious Diseases, 46 (s2), S104–S111. doi: http://doi.org/10.1086/523331
  34. Mayes, T., Gottschlich, M. M., James, L. E., Allgeier, C., Weitz, J., Kagan, R. J. (2015). Clinical Safety and Efficacy of Probiotic Administration Following Burn Injury. Journal of Burn Care & Research, 36 (1), 92–99. doi: http://doi.org/10.1097/bcr.0000000000000139
  35. Marteau, P. R. (2002). Probiotics in clinical conditions. Clinical Reviews in Allergy & Immunology, 22 (3), 255–273. doi: http://doi.org/10.1007/s12016-002-0011-0
  36. Shanahan, F. (2012). A Commentary on the Safety of Probiotics. Gastroenterology Clinics of North America, 41 (4), 869–876. doi: http://doi.org/10.1016/j.gtc.2012.08.006
  37. Doron, S., Snydman, D. R. (2015). Risk and Safety of Probiotics. Clinical Infectious Diseases, 60 (suppl_2), S129–S134. doi: http://doi.org/10.1093/cid/civ085
  38. Gasser, F. (1994). Safety of lactic-acid bacteria and their occurrence in human clinical infections. Bulletin de L'Institut Pasteur, 92, 45–67.
  39. Saxelin, M., Chuang, N.-H., Chassy, B., Rautelin, H., Makela, P. H., Salminen, S., Gorbach, S. L. (1996). Lactobacilli and Bacteremia in Southern Finland, 1989-1992. Clinical Infectious Diseases, 22 (3), 564–566. doi: http://doi.org/10.1093/clinids/22.3.564
  40. Borriello, S. P., Hammes, W. P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M., Valtonen, V. (2003). Safety of Probiotics That Contain Lactobacilli or Bifidobacteria. Clinical Infectious Diseases, 36 (6), 775–780. doi: http://doi.org/10.1086/368080
  41. Bernardeau, M., Vernoux, J. P., Henri-Dubernet, S., Guéguena, M. (2008). Safety assessment of dairy microorganisms: the Lactobacillus genus. International Journal of Food Microbiology, 126 (3), 278–285. doi: http://doi.org/10.1016/j.ijfoodmicro.2007.08.015
  42. Guidelines for the Evaluation of Probiotics (2002). Food Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food London Ontario. Canada. Available at: https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
  43. Saarela, M., Mogensen, G., Fondén, R., Mättö, J., Mattila-Sandholm, T. (2000). Probiotic bacteria: safety, functional and technological properties. Journal of Biotechnology, 84 (3), 197–215. doi: http://doi.org/10.1016/s0168-1656(00)00375-8
  44. Ishibashi, N., Yamazaki, S. (2001). Probiotics and safety. The American Journal of Clinical Nutrition, 73 (2), 465s–470s. doi: http://doi.org/10.1093/ajcn/73.2.465s
  45. Doron, S., Hibberd, P. L., Goldin, B., Thorpe, C., McDermott, L., Snydman, D. R. (2015). Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities. Antimicrobial Agents and Chemotherapy, 59 (8), 4593–4599. doi: http://doi.org/10.1128/aac.00300-15
  46. Holzapfel, W. H., Haberer, P., Geisen, R., Björkroth, J., Schillinger, U. (2001). Taxonomy and important features of probiotic microorganisms in food and nutrition. The American Journal of Clinical Nutrition, 73 (2), 365s–373s. doi: http://doi.org/10.1093/ajcn/73.2.365s
  47. Klein, G. (2011). Antibiotic Resistance and Molecular Characterization of Probiotic and ClinicalLactobacillusStrains in Relation to Safety Aspects of Probiotics. Foodborne Pathogens and Disease, 8 (2), 267–281. doi: http://doi.org/10.1089/fpd.2010.0672
  48. Stefanov, A. V. (Ed.) (2002). Doklinicheskie issledovaniia lekarstvennykh sredstv. Metodicheskie rekomendatsii. Kyiv: Avitsena, 568.
  49. Liaskovskii, T. M., Podgorskii, V. S. (2005). Otsenka probiotikov soglasno rekomendatsii mezhdunarodnykh organizatsii (FAO/WHO). Mikrobiologicheskii zhurnal, 67 (6), 104–112.

Downloads

Published

2020-02-28

How to Cite

Lazarenko, L., Bubnov, R., Babenko, L., Melnykova, O., & Spivak, M. (2020). Methodical approaches of estimation of probiotics` quality and rational principles of their usage in clinical practice. ScienceRise: Biological Science, (1 (22), 25–30. https://doi.org/10.15587/2519-8025.2020.202216

Issue

No. 1 (22) (2020)

Section

Biological Sciences

License

Copyright (c) 2020 Liudmyla Lazarenko, Rostyslav Bubnov, Lidiia Babenko, Olexandra Melnykova, Mykola Spivak

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.